VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,114,331 | -43.9% | 257,947 | -14.4% | 0.00% | -57.1% |
| Q2 2023 | $1,985,112 | -7.3% | 301,231 | -4.5% | 0.01% | -78.1% |
| Q1 2023 | $2,141,356 | +97.1% | 315,369 | +114.5% | 0.03% | +60.0% |
| Q4 2022 | $1,086,626 | -48.6% | 147,040 | -24.3% | 0.02% | -65.5% |
| Q2 2022 | $2,116,000 | +192.3% | 194,164 | +203.1% | 0.06% | +205.3% |
| Q1 2022 | $724,000 | -57.5% | 64,050 | -41.0% | 0.02% | -64.2% |
| Q4 2021 | $1,702,000 | – | 108,491 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |